Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony rozpoznaniem rak płuca z małymi komórkami (w stadium ograniczonym lub zaawansowanym)
- •Pacjenci, którym zalecono radioterapię klatki piersiowej metodą terapii protonowej (dawka 30-66 Gy w 15-33 frakcjach)
- •Wiek 18 lat i więcej
✗ Disqualifies
- •Wcześniejsza radioterapia, która mogłaby zakłócić planowane leczenie
- •Ciąża
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 17, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Winship Cancer Institute
Atlanta, United States
Trial contact
Kristin Higgins, MD
Allyson Anderson
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/18/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.